SCHEMBL31429009

SCHEMBL31429009

O=C(c1cc2ncccc2o1)N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.52
MAPT P10636 2/20 0.48
POLB P06746 1/20 0.48
ALDH1A1 P00352 8/20 0.47
HPGD P15428 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPC1 O15118 2/20 0.46
HRH4 Q9H3N8 1/20 0.45
RIPK1 Q13546 1/20 0.45
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PIK3CD O00329 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428444 0.77 RAB9A (0.57) RAB9AMAPTPOLBALDH1A1HPGD
SCHEMBL18889298 0.77 MAPT (0.78) RAB9AMAPTPOLBALDH1A1HPGD
SCHEMBL31428574 0.75 RAB9A (0.55) RAB9AMAPTPOLBALDH1A1HPGD
SCHEMBL31428832 0.75 RAB9A (0.55) RAB9AMAPTPOLBALDH1A1HPGD
SCHEMBL29686936 0.75 CHRNB2 (0.44) RAB9AMAPTPOLBALDH1A1NPC1
SCHEMBL4128614 0.75 KDM4E (0.49) RAB9AMAPTPOLBALDH1A1HPGD
SCHEMBL29689092 0.75 KDM4E (0.49) RAB9AMAPTPOLBALDH1A1HPGD
SCHEMBL5584787 0.74 RAB9A (0.53) RAB9AMAPTPOLBALDH1A1HPGD
SCHEMBL27937992 0.74 POLB (0.65) RAB9AMAPTPOLBALDH1A1HPGD
SCHEMBL17749939 0.73 ALDH1A1 (0.44) RAB9AMAPTPOLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS RAB9A 67/4885MAPT 4513/4885POLB 3285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.